China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC

BOSTON, Sept. 7 /PRNewswire/ -- China PharmaHub Corp. (OTC Bulletin Board:CPHB) ("PharmaHub"), which recently merged with World Wide Relics (OTC Bulletin Board: WRLC) and, effective August 23, 2010, changed its name from World Wide Relics, Inc. to China PharmaHub Corp., announced today that effective Tuesday, September 7, 2010, its stock shall begin trading under the symbol "CPHB."  The change has been announced in FINRA's Daily List for September 3, 2010 to be effective September 7, 2010.  

(Logo: http://photos.prnewswire.com/prnh/20100907/LA60053LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100907/LA60053LOGO)

The purpose of the name change is to better reflect PharmaHub's goals of becoming a global pharmaceutical HUB that specializes in the identification, licensing, development and commercialization of pharmaceutical and healthcare products and technologies that its management believes could make a significant difference to patients and society worldwide. PharmaHub's corporate goal is to create maximum value from existing intellectual properties and technologies of its global partners by utilizing its broad-base of knowledge, understanding and resource allocation ability in the pharmaceutical and healthcare industries.

Richard Lui, CEO of PharmaHub stated, "We are thrilled to being trading under a symbol which better reflects our corporate goals and also reflects the name under which we were originally founded.  Since founding, we have been forming relationships with and have built what we believe is a strong foundation of strategic alliances, partnerships and joint ventures.  We believe that our new trading symbol reflects the progress we have made in becoming a solid bridge between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, with initial emphasis in the U.S. and Europe.  

About PharmaHub:

China PharmaHub Corp. is engaged in the business of licensing, developing and the commercialization of pharmaceutical and healthcare products and technologies between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, with initial emphasis in the United States and Europe. Management believes that PharmaHub brings a unique wealth of resources to assist scientists and companies in bringing their ideas to reality.  PharmaHub's corporate headquarters are located in California, with offices in Boston and China. For more information visit www.chnpharmahub.com.

Forward-Looking Statements

This press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein.

SOURCE China PharmaHub Corp.